The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 04, 2025

Filed:

Jun. 28, 2021
Applicants:

Crispr Therapeutics Ag, Zug, CH;

Bayer Healthcare Llc, Whippany, NJ (US);

Inventors:

Albena Kantardzhieva, Cambridge, MA (US);

Akiko Noma, Cambridge, MA (US);

Abraham Scaria, Cambridge, MA (US);

Assignees:

CRISPR THERAPEUTICS AG, Zug, CH;

BAYER HEALTHCARE LLC, Whippany, NJ (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/11 (2006.01); A61P 27/00 (2006.01); C12N 9/22 (2006.01);
U.S. Cl.
CPC ...
C12N 15/11 (2013.01); A61P 27/00 (2018.01); C12N 9/22 (2013.01); C12N 2310/20 (2017.05); C12N 2800/80 (2013.01);
Abstract

The present application provides materials and methods for treating a patient with Usher Syndrome Type 2A, both ex vivo and in vivo; materials and methods for editing a USH2A gene in a human cell; materials and methods for editing an USH2A gene containing an IVS40 mutation; materials and methods for treating a patient with an USH2A gene containing an IVS40 mutation; and a method for deleting a sequence comprising an IVS40 mutation within a USH2A gene of a cell. The present application also provides one or more gRNAs or sgRNAs for editing an USH2A gene containing an IVS40 mutation. The present application provides a therapeutic for treating a patient with Usher Syndrome Type 2A. The present application also provides a kit for treating a patient with Usher Syndrome Type 2A.


Find Patent Forward Citations

Loading…